Skip to main content

Table 3 The multivariate Cox regression analysis for DFS and OS in 70 patients with invasive breast cancer.

From: Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer

 

Significance Multivariate P (Cox regression)

95%Confidence Interval

Hazard ratio

Disease-free survival

   

   LVD

0.015*

1.289–11.007

3.766

   ER

0.045*

0.134–0.976

0.361

   c-erbB-2

0.007*

1.509–13.731

4.552

   LVI

0.025*

1.162–9.648

3.348

   VEGF-C expression

0.167

  

   COX-2 expression

0.330

  

Overall survival

   

   LVD

0.002*

2.021–20.595

6.452

   c-erbB-2

0.028*

1.142–10.199

3.413

   VEGF-C expression

0.155

  

   COX-2 expression

0.375

  
  1. *Statistically significant (Cox regression).